Skip to Content

Goldman Sachs Intl Eq Insghts Inv GCITX

Medalist Rating as of | See Goldman Sachs Investment Hub
  • NAV / 1-Day Return 14.50  /  +1.19 %
  • Total Assets 1.8 Bil
  • Adj. Expense Ratio
    0.930%
  • Expense Ratio 0.930%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment
  • Status Open
  • TTM Yield 2.62%
  • Turnover 157%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 11:44 PM GMT+0

Morningstar’s Analysis GCITX

Will GCITX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A true quant offering.

Senior Analyst Jack Shannon

Jack Shannon

Senior Analyst

Summary

An impressive group of researchers runs Goldman Sachs International Equity Insights in a true quantitative fashion. For investors seeking an international large-cap option, this strategy is a decent offering.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GCITX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 18.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

3.69 61.2 Mil
Healthcare

ASML Holding NV

3.43 56.8 Mil
Technology

Cash

1.96 32.4 Mil
Cash and Equivalents

Nestle SA

1.76 29.2 Mil
Consumer Defensive

Roche Holding AG

1.62 26.8 Mil
Healthcare

ABB Ltd

1.52 25.3 Mil
Industrials

AstraZeneca PLC ADR

1.42 23.6 Mil
Healthcare

Munchener Ruckversicherungs-Gesellschaft AG

1.41 23.4 Mil
Financial Services

Industria De Diseno Textil SA Share From Split

1.33 22.0 Mil
Consumer Cyclical

Honda Motor Co Ltd

1.32 21.9 Mil
Consumer Cyclical